Time Course of Insulin-receptor Binding and Insulin-induced Lipogenesis in Isolated Rat Fat Cells
Overview
Authors
Affiliations
1. Isolated rat fat cells were incubated at 37 degrees with [U-14C]-glucose 0.55 mM and 125I-labeled insulin. The amount of receptor-bound 125I-labeled insulin and the rate of insulin-induced 14C-lipid synthesis were assessed during association and dissociation of 125I-labeled insulin. 2. The rate of 14C-lipid synthesis was constant from zero time in the absence of insulin and in the presence of insulin in a high concentration (0.7 muM). With insulin in a low concentration (56 pM) the insulin-induced rate of 14C-lipid synthesis was proportional to the receptor occupancy; the receptor binding reached equilibrium and the rate of 14C-lipid synthesis reached a constant value after 30 to 45 min. With insulin in a concentration of 0.7 nM the rate of 14C-lipid synthesis reached a steady state before equilibrium of the receptor binding was obtained. 3. Ater preincubation with 56 pM 125I-labeled insulin followed by removal of extracellular insulin the decrease in the rate of insulin induced 14C-lipid synthesis followed the decrease in receptor occupancy with a half-time of about 10 min. After preincubation with insulin in concentrations of 0.28, 0.56, and 1.4 nM a maximum rate of 14C-lipid synthesis was maintained for about 8, 15, and 30 min, respectively. 4. The following model is suggested. Binding of insulin to the previously described receptors with a dissociation constant of about 3 nM (Gammeltoft, S., and Gliemann, J. (1973) Biochim. Biophys Acta 320, 16-32) represents the first step in the action of insulin on lipid synthesis from glucose. The receptor occupancy is rate-determining at low concentrations of insulin, i.e. when the occupancy is small (about 2 percent or less). At higher insulin concentrations some other step becomes rate-determining and the higher occupancy at equilibrium therefore causes no further increase in the steady state lipogenesis. However, a high receptor occupancy causes a prolonged maintenance of a maximal (or near-maximal) effect after removal of insulin from the medium.
β Cell function and plasma insulin clearance in people with obesity and different glycemic status.
Mittendorfer B, Patterson B, Smith G, Yoshino M, Klein S J Clin Invest. 2021; 132(3).
PMID: 34905513 PMC: 8803344. DOI: 10.1172/JCI154068.
Wueest S, Schoenle E, Konrad D Adipocyte. 2013; 1(3):153-156.
PMID: 23700524 PMC: 3609098. DOI: 10.4161/adip.19910.
Marcelino H, Veyrat-Durebex C, Summermatter S, Sarafian D, Miles-Chan J, Arsenijevic D Diabetes. 2012; 62(2):362-72.
PMID: 22961086 PMC: 3554390. DOI: 10.2337/db12-0255.
Wueest S, Rapold R, Rytka J, Schoenle E, Konrad D Diabetologia. 2008; 52(3):541-6.
PMID: 19048227 DOI: 10.1007/s00125-008-1223-5.
Williams D Neurosci Lett. 2008; 443(1):27-31.
PMID: 18672028 PMC: 2597579. DOI: 10.1016/j.neulet.2008.07.038.